Strangvac, a vaccine against equine strangles, has been granted marketing authorisation in Norway
Stockholm, August 23, 2021 - Intervacc AB (“Intervacc”) announced today that the Norwegian Medicines Agency (NoMA) has granted a marketing authorisation for Strangvac within Norway. Strangvac is a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally.
“We are very pleased that NoMA has granted a marketing authorization for Strangvac in Norway. The approval follows the positive opinion given by the European Medicines Agency, EMA, in June this year. This is an important step since we now can market the vaccine throughout the Nordic region as